Dihydrolipoamide Branched Chain Transacylase E2 (DBT) (N-Term) Peptide
DBT
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all DBT products
- DBT (Dihydrolipoamide Branched Chain Transacylase E2 (DBT))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- EWYVKEGDTV SQFDSICEVQ SDKASVTITS RYDGVIKKLY YNLDDIAYVG
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-DBT Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeat freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- DBT (Dihydrolipoamide Branched Chain Transacylase E2 (DBT))
- Synonyms
- BCATE2 Peptide, BCKAD-E2 Peptide, BCKADE2 Peptide, E2 Peptide, E2B Peptide, D3Wsu60e Peptide, im:7147214 Peptide, zgc:103768 Peptide, E2b Peptide, dihydrolipoamide branched chain transacylase E2 Peptide, hypothetical protein Peptide, dihydrolipoamide branched chain transacylase E2 L homeolog Peptide, DBT Peptide, dbt Peptide, CpipJ_CPIJ006326 Peptide, BDBG_05874 Peptide, NAEGRDRAFT_78509 Peptide, VDBG_04820 Peptide, PGTG_17722 Peptide, Dbt Peptide, dbt.L Peptide
- Target Type
- Viral Protein
- Background
-
The function of this protein remains unknown.
Protein Size: 320 - Molecular Weight
- 35 kDa
- UniProt
- Q5VVL7
-
You are here:
